Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 2

Sponsor

Cancer Type

Breast 10Plasma cell 3Lymphoid 3Gastrointestinal 3Other neoplasm 2Other hematologic neoplasm 2Myeloid 2Head & Neck 2Genitourinary 2Dermatologic 2CNS 2Thoracic 1Sarcoma 1

Conditions

Melanoma 1Kidney Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Basal Cell 1

Interventions

Nivolumab 168Ipilimumab 152pembrolizumab 143Cyclophosphamide 126Interleukin-2 70aldesleukin 69fludarabine phosphate 68Radiotherapy 67Biopsy 53Temozolomide 48Blood Specimen Collection 45Peripheral Blood Stem Cell Transplantation 44fludarabine 43Radiosurgery 40trametinib 38Vemurafenib 36dabrafenib 33sargramostim 32Bevacizumab 31Aminolevulinic Acid 31Magnetic Resonance Spectroscopy 30Mycophenolic Acid 29Specimen Handling 28Whole-Body Irradiation 27Photochemotherapy 26Imiquimod 26CTLA-4 Antigen 26Busulfan 26Tacrolimus 25Surveys and Questionnaires 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Patient Reported Outcome Measures × Dermatologic × Clear all
NCT04146064 2026-05-08

Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response

University Health Network, Toronto

Completed
190 enrolled
DermatologicGenitourinaryHead & Neck

Carcinoma, Transitional Cell, Head and Neck Neoplasms, Kidney Neoplasms, Melanoma

NCT06448936 2025-04-03

FACE-QOL

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Unknown
750 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡